LONDON – Final results of the community pilot in Liverpool, U.K., that used the controversial Innova Medical Group Inc. lateral flow device to test all comers for COVID-19, show new cases fell by 21% ...

The proportion of people with current covid-19 infection missed by the Innova lateral flow test (LFT) is substantial enough to be of clinical importance, particularly when testing people without ...

Food and Drug Administration last week requested that Innova Medical Group stop sales of its COVID antigen rapid qualitative test and warned the public against using the test, citing concerns about ...

UK government plans to widen the roll out of the Innova lateral flow test without supporting evidence risks serious harm, warn experts in The BMJ today. More than £1 billion have been spent on ...

UK government plans to widen the roll out of the Innova lateral flow test without supporting evidence risks serious harm, warn experts in The BMJ today. More than £1 billion have been spent on ...

University of Birmingham (U.K.) signs licensing deal with Innova Medical Group – the world's largest COVID-19 at-home self-test provider - to Commercialize New Proven Testing Method in the Global ...

The proportion of COVID-19 infections missed by the Innova lateral flow test (LFT) are “substantial enough to be of clinical importance” according to an analysis published in The BMJ. The study by ...

PASADENA, Calif. and CAERPHILLY, South Wales, May 26, 2021 /PRNewswire/ -- Innova Medical Group, the world's largest provider of rapid antigen tests, has announced an initial investment in South Wales ...

The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds ...